Core Viewpoint - The article highlights the recent performance of various listed companies based on institutional research activities, emphasizing the positive stock price movements of companies like 精智达 and 信立泰, driven by strategic developments and market demand [3][5]. Group 1: Institutional Research and Stock Performance - A total of 234 listed companies disclosed institutional research minutes this week, with nearly 40% of these companies experiencing positive stock returns [3]. - 精智达 (688627) saw a stock price increase of 17.68% after being researched by 138 institutions, focusing on its core business in display panels and semiconductor testing equipment [3]. - Other companies like 海博思创, 新坐标, and 沃尔德 also reported significant stock price increases of 32.19%, 25.03%, and 20.81% respectively during the week [3]. Group 2: Company Developments and Strategic Focus - 精智达's management indicated that the company has successfully completed its annual targets for FT testing machines and is making steady progress in KGSDCP testing machines, with strong demand in the aging testing machine sector [4]. - The company is building a complete product line around AI demands, focusing on storage, computing power, and human-machine interaction, positioning itself as a foundational player in semiconductor testing equipment for the AI era [5]. - 信立泰 hosted a roadshow and received inquiries about the impact of geopolitical factors on its US subsidiary and the role of AI in shortening R&D cycles, indicating a proactive approach to addressing investor concerns [7]. Group 3: Mergers and Collaborations - 盟科药业 announced a significant change in its controlling shareholder and plans to raise up to 10.33 billion yuan through a private placement, which will enhance its operational capabilities [10]. - 高伟达's strategic partnership with 蚂蚁数科 aims to leverage AI and big data in financial technology, highlighting the importance of collaboration in enhancing service capabilities and market reach [12].

Summary of Key Points Core Viewpoint - This week, 234 listed companies disclosed institutional research records, with nearly 40% of the companies experiencing positive stock performance, indicating a strong interest from institutional investors in various sectors [1][2]. Group 1: Institutional Research and Stock Performance - 32.19% increase in stock price for Haibo Sichuang during the week [1] - 25.03% increase in stock price for Xin Zuo Biao, marking its first board appearance [1] - 20.81% increase in stock price for World [1] Group 2: Notable Companies and Their Developments - Jingzhida (688627) received attention from 138 institutions, with a stock price increase of 17.68%. The company focuses on display panels and semiconductor testing equipment, highlighting advancements in storage testing and AI-related product lines [2] - Xintai's stock rose 15.81% after hosting a roadshow with 77 institutional investors. The company specializes in pharmaceuticals and medical devices, with over 80% of revenue from its formulation business [2] - Mengke Pharmaceutical hosted 66 institutions and announced a change in its controlling shareholder, planning to raise up to 1.033 billion yuan through a private placement [2] Group 3: Strategic Partnerships and Collaborations - Gaowei Da attracted 40 institutional investors due to a strategic partnership with Ant Group, focusing on AI and big data in financial technology [2] - The partnership aims to leverage both companies' strengths to enhance service capabilities and technology solutions in the financial sector [2]

Group 1 - A total of 234 listed companies disclosed institutional research records this week, with nearly 40% of them achieving positive stock returns [1] - The stock price of Jingzhida (688627) increased by 17.68% after receiving 138 institutional inquiries, focusing on its storage testing and semiconductor testing equipment [1][2] - Xintai's stock rose by 15.81% after hosting a roadshow with 77 institutional investors, with its core revenue source being over 80% from its formulation business [2] Group 2 - Mengke Pharmaceutical announced a stock issuance plan at a price of 6.3 yuan per share, raising up to 1.033 billion yuan, with Haiqing Pharmaceutical becoming the controlling shareholder [3] - Haiqing Pharmaceutical will leverage its experience in raw material drug development to enhance Mengke's product cost efficiency and profitability [3] - Gaowei Technology received attention from over 40 institutions due to its strategic partnership with Ant Group, focusing on AI and financial technology [4][5]

Wind数据显示，截至9月26日16时，本周共计234家上市公司披露机构调研纪要。从赚钱效应来看，本周近四成机构调研公司股价实现正收益，其中海博 思创周内股价累计上涨32.19%，新坐标周内迎来首板，上涨25.03%，沃尔德股价累计上涨20.81%。冰轮环境本周举行三场调研活动，潍柴动力、章源钨 业、金力永磁、宁波银行等10家公司周内举办两场调研。 从热门调研标的来看，精智达（688627）本周接受138家机构调研，周内股价涨幅为17.68%。精智达主营业务聚焦显示面板与半导体测试设备两大核心赛 道。在调研中，机构重点询问该公司存储测试业务、算力芯片测试业务、探针卡业务等多项业务进展。 | 30分 60分 日 K 分时 | 周K 目K 叠加 ▼前复权 ▼ 真他 ▼ | 1 50 | 精智达1(68862 | | --- | --- | --- | --- | | | | 180 00 | | | | | 100.00 | | | | | 90.00 | | | | | 80.00 | | | | | 70.00 | | | | 688627 区间统计 | | | | 开始时间: 2025/09/01 ◀ ▶ ...

Group 1 - As of September 26, 234 listed companies disclosed institutional research minutes, with nearly 40% of these companies experiencing positive stock returns during the week [1] - Notable stock price increases included Haibosi Chuang up 32.19%, New Coordinates up 25.03%, and World up 20.81% [1] - Jingzhida (688627) received attention from 138 institutions, with a stock price increase of 17.68%, focusing on display panels and semiconductor testing equipment [1] Group 2 - Jingzhida's executives reported that the high-speed FT testing machine met its annual goals ahead of schedule, and the aging testing machine is in high demand [3] - The company is strategically expanding its product line to meet AI era demands, focusing on storage, computing power, and human-computer interaction [3] - Xintai, a pharmaceutical company, hosted a roadshow and received 77 institutional investors, with a stock price increase of 15.81% [3] Group 3 - Xintai addressed investor inquiries regarding the impact of geopolitical factors on its U.S. subsidiary and the role of AI in research efficiency [5] - Mengke Pharmaceutical announced a stock issuance plan to raise up to 1.033 billion yuan, with a new controlling shareholder [7] - Mengke's collaboration with Haiqing Pharmaceutical aims to enhance product cost efficiency and profitability through shared expertise in raw material drug development [7] Group 4 - Xinghui Entertainment, Gaoweida, and Dansheng Technology received attention from over 40 institutions, with Gaoweida's partnership with Ant Group being a focal point [9] - The strategic partnership aims to enhance innovation in smart customer acquisition, big data risk control, and AI technology [9] - Gaoweida emphasized its strengths as a leading financial technology company with extensive service networks in the financial sector [9]

Group 1 - A total of 234 listed companies disclosed institutional research minutes this week, with nearly 40% of them achieving positive stock returns [1] - Companies such as Haibo Sichuang, New Coordinates, and World achieved significant stock price increases of 32.19%, 25.03%, and 20.81% respectively [1] - Jingzhida received attention from 138 institutions, with a stock price increase of 17.68%, focusing on its core business in display panels and semiconductor testing equipment [1][2] Group 2 - Jingzhida's executives highlighted the strong demand for aging testing machines and their advantages in advanced temperature control and mass production experience [1][2] - Xinlitai hosted a roadshow in Shenzhen, attracting 77 institutional investors and achieving a stock price increase of 15.81%, with a focus on its pharmaceutical and medical device business [2] - Mengke Pharmaceutical announced a private placement plan to raise up to 1.033 billion yuan, with Nanjing Haiqing Pharmaceutical becoming the controlling shareholder [3] Group 3 - Highwei Technology received attention from over 40 institutions due to its strategic partnership with Ant Group, focusing on AI and financial technology [4] - Highwei emphasized the synergy between its extensive service network in financial institutions and Ant Group's technological advantages, aiming for a dual empowerment model [4] - The procurement plan will align with project implementation, prioritizing key modules such as credit fraud prevention and AI traffic operations [4]

Group 1 - The company has successfully completed its annual target for high-speed FT testing machines ahead of schedule [1] - The KGSD CP testing machine is steadily progressing in validation, with continuous iteration and upgrades based on storage industry technology solutions [1] - There is a strong demand for aging testing machines, and the company possesses advantages in advanced temperature control, aging repair, power and current control, and mass production experience [1] Group 2 - The company is building a complete product line to meet the demands of the AI era, focusing on core needs such as storage, computing power, and integrated computing-storage solutions, as well as human-machine interaction [1] - The company is expanding its business based on the Chinese market, customer needs, and development advantages [1] - Semiconductor testing equipment is viewed as the foundational technology for the AI era, and the company is confident about its future development [1]

Summary of the Conference Call for 精智达 Industry and Company Overview - The conference call discusses the developments and strategies of 精智达, a company specializing in semiconductor testing equipment and solutions, particularly in the fields of AI, OLED, and MEMS technology [2][3][4]. Key Points and Arguments Business Developments - 精智达's aging testing machines and low-speed FT testing machines account for over 70% of its product mix, while consumables and components make up nearly 20% [2][3]. - The company has achieved a historic breakthrough with its high-speed FT testing machines, securing significant orders and preparing for mass production [2][3]. - The company has established strategic partnerships with domestic AI chip manufacturers, launching a prototype for SoC testing machines in 2023, with further developments expected by mid-2024 [2][3][4]. - 精智达 is the only domestic supplier capable of mass-producing MEMS process carbon probe cards, positioning itself strongly for new orders [2][4]. - The company has secured a multi-million dollar order from Meta to provide optical testing equipment for AR glasses, marking its status as a core global supplier [2][4]. Market Position and Strategy - 精智达 has the highest market share in the OLED EAC segment and module segment in China, responding to the expansion needs of major clients like 京东方, 维信诺, and 华星光电 [2][3][4]. - The company aims to build a complete product line to meet the demands of the AI era, focusing on storage, computing power, and human-computer interaction [5][8]. - 精智达 is positioned as the only supplier in China providing a systematic storage testing solution, achieving over 9G speeds in DRAM testing [6][14]. Future Growth and Challenges - The company anticipates significant growth in its probe card business due to high demand and limited supply from international competitors [10]. - There are plans to expand into NAND testing machines, leveraging existing DRAM testing capabilities [12]. - The display business is expected to maintain high profitability, with historical highs in gross margins and continued order support projected for the next three to five years [16][17][18]. Additional Important Information - The company has a comprehensive layout in the storage testing equipment sector, ensuring it meets the complex demands of new semiconductor technologies [9][12]. - The OLED and panel business is projected to have substantial opportunities for investment and growth, with significant capital plans from domestic manufacturers [15][18]. - The company is focused on maintaining its competitive edge by aligning its product offerings with the evolving needs of the market and its strategic clients [13].

Group 1: Company Research Insights - Southern Fund recently conducted research on 9 listed companies, focusing on their strategic directions and performance metrics [1][2][3][4][5][6][7][8][9] - Potevio Technology is focusing on satellite internet and has established a joint laboratory with Xidian ISN for low-orbit satellite communication products [1] - Longi Green Energy reported a main revenue of 32.813 billion yuan, a year-on-year decrease of 14.83%, while its net profit attributable to shareholders was -2.569 billion yuan, an increase of 50.88% year-on-year [2] - Hehe Information is accelerating new product launches and focusing on AI product strategies, with over 60% of its workforce in R&D [3] - Zoomlion is cautiously optimistic about market demand, with a significant increase in overseas revenue by approximately 15% [4] - Aotwei's semiconductor equipment gross margin is low due to long acceptance cycles, but it expects improvement with increased orders for aluminum wire bonding machines [5] - Jingzhida achieved a revenue of 444 million yuan in the first half of 2025, a year-on-year increase of 22.68%, with over 70% of revenue from semiconductor business [6] - Zhongke Lanyun reported a sales revenue of 444.45 million yuan in Q2, with a quarter-on-quarter growth of 21% [7] - Youyou Green Energy's revenue reached 720 million yuan in the first half of 2025, with a slight year-on-year increase of 0.11% [8] - Fuan Energy's total assets were 19.906 billion yuan, with an operating income of 15.338 billion yuan in the first half of 2025, maintaining stable growth [9] Group 2: Financial Performance Metrics - Longi Green Energy's second-quarter revenue was 19.161 billion yuan, a year-on-year decrease of 8.12%, with a net profit of -1.133 billion yuan, an increase of 60.66% [2] - Zoomlion's mid-term dividend payout exceeded 60%, reflecting a long-term stable return philosophy [4] - Aotwei's gross margin is expected to improve as it expands into advanced packaging and solid-state battery equipment [5] - Jingzhida's new orders are gradually increasing its market share, with a focus on high-end testing machines [6] - Zhongke Lanyun's net profit reached 86.2341 million yuan in Q2, with a quarter-on-quarter growth of 92.10% [7] - Youyou Green Energy's overall gross margin was 29.6%, with overseas sales gross margin at 55.1% [8] - Fuan Energy's cash flow from operating activities was 686 million yuan, a year-on-year increase of 602.45% [9]